Evolent Health (NYSE: EVH) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $49.45 million versus the consensus estimate of $47.4 million.

GUIDANCE:

Evolent Health sees Q2 2016 revenue of $51-52 million.

Evolent Health sees FY2016 revenue of $212-220 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.